NeuroOne Medical Technologies Corp (NMTC)

NASD · Healthcare · Medical Devices · USA

NeuroOne Medical Technologies Corp is a micro cap company (market value under $300 million) in the Medical Devices industry.

NeuroOne Medical Technologies Corp develops diagnostic, ablation, and deep brain stimulation devices for neurological conditions such as epilepsy and Parkinson's disease, and pain management solutions. The company has received FDA clearance for four devices: Evo Cortical and Evo sEEG electrodes for brain monitoring and stimulation, and OneRF Brain and OneRF TN Ablation Systems for creating radiofrequency lesions.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the NeuroOne Medical Technologies Corp stock.

Our verdict on NMTC

Fairly valued: intrinsic value $0.72 per share, market price $0.71, margin of safety 1.3% (as of 2026-11-17).

Its liquidation floor, current assets minus every liability, values the shares at $0.72; the price of $0.71 is 1% below that value.

ETFs with the most weight in NMTC

More on NMTC

Browse

Peers in Medical Devices

All 140 Medical Devices stocks

Cheaper than NMTC in Medical Devices

14 more in this industry show a wider margin of safety.

Is NMTC undervalued or overvalued?

NMTC is fairly valued (as of the 2026-11-17 close). Its liquidation floor, current assets minus every liability, values the shares at $0.72; the price of $0.71 is 1% below that value.

What is the intrinsic value of NMTC?

$0.72 per share (as of the 2026-11-17 close), against a market price of $0.71. That is a margin of safety of 1.3%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.